![Margaret Olinger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Margaret Olinger
Keine laufenden Positionen mehr
Vermögen: 9 051 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Margaret Olinger
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Margaret Olinger
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Apnimed, Inc.
![]() Apnimed, Inc. BiotechnologyHealth Technology Apnimed, Inc. operates as a clinical-stage company. It discovers novel pharmaceutical therapies for sleep apnea and related disorders. The company was founded by Lawrence G. Miller and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Boehringer Ingelheim Pharmaceuticals, Inc.
![]() Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The American Institute of Certified Public Accountants
![]() The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Monmouth University | College/University | Undergraduate Degree | |
AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Morningside Group Ltd.
![]() Morningside Group Ltd. Investment ManagersFinance Morningside Group (Morningside Group) is a venture capital and private equity firm founded in 1986 by Lok Chung Chan and Chi Chung Chan. The firm is headquartered in Hong Kong. | Investment Managers | Private Equity Investor | |
MedAnnex Ltd.
![]() MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Revolo Biotherapeutics Ltd.
![]() Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Meissa Vaccines, Inc.
![]() Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Ma Pharmaceuticals, Inc. | Director/Board Member | ||
Adjuvance Technologies, Inc.
![]() Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | Pharmaceuticals: Generic | Director/Board Member | |
Masters Pharmaceuticals Ltd.
![]() Masters Pharmaceuticals Ltd. Specialty StoresRetail Trade Masters Pharmaceuticals Ltd. provides global healthcare solutions. It distributes prescription and OTC drugs, medical devices and supplies. The firm offers acetylcysteine, aciclovir, amiloride hcl, amitriptyline, baclofen and budesonide products. It supplies advanced medicines to hospitals, pharmacists, clinics and Governments. The company was founded by Suzad Masters and Zulf Masters in 1984 and is headquartered in Elstree, the United Kingdom. | Specialty Stores | Director/Board Member | |
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Director/Board Member | |
InCarda Therapeutics, Inc.
![]() InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
K-Gen, Inc.
![]() K-Gen, Inc. Miscellaneous Commercial ServicesCommercial Services K-Gen, Inc. is an American biotechnology company. The private company is based in San Francisco. | Miscellaneous Commercial Services | Director/Board Member | |
Artugen Therapeutics Ltd.
![]() Artugen Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Artugen Therapeutics Ltd. develops precision treatments for infections. The company was founded in 2015 and is headquartered in Concord, MA. | Pharmaceuticals: Generic | Director/Board Member | |
Cognoa, Inc.
![]() Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Director/Board Member | |
NUCANA PLC | Biotechnology | Director/Board Member | |
Serica Technologies, Inc.
![]() Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tufts University School of Medicine | College/University | Doctorate Degree | |
Atreaon, Inc.
![]() Atreaon, Inc. Pharmaceuticals: OtherHealth Technology Atreaon, Inc. develops proteins for diseases treatment. It operates as a pharmaceutical company that develops medicines for the treatment of arthritis. The company was founded on December 19, 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Other | Director/Board Member | |
ProterixBio, Inc.
![]() ProterixBio, Inc. Medical SpecialtiesHealth Technology ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
Advanced Cell Diagnostics, Inc.
![]() Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
Institute of Management Accountants, Inc.
![]() Institute of Management Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Institute of Management Accountants, Inc. provides accountants and financial services. The company was founded in 1919 and is headquartered in Montvale, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
CENTURY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
G.D. Searle LLC | Corporate Officer/Principal | ||
Harvard Law School | College/University | Graduate Degree | |
Syracuse University | College/University | Undergraduate Degree | |
Cullinan Mica Corp.
![]() Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology PDI Therapeutics, Inc. develops therapeutics that enhances the body’s ability to recognize and destroy tumor cells. The company is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
BAYER AG | Pharmaceuticals: Major | Sales & Marketing | |
CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
RBC Capital Markets LLC
![]() RBC Capital Markets LLC Investment Banks/BrokersFinance RBC Capital Markets LLC is a full-service brokerage and financial services firm headquartered in New York City. They are a direct subsidiary of RBC USA Holdco Corp. and a wholly-owned indirect subsidiary of Royal Bank of Canada (TSE, NYSE: RY). Founded in 2010, the firm is comprised of 3 major business lines: the Private Client Group, the Fixed-Income Group and the Clearing and Execution Services Group. The Private Client Group serves individual investors, while the Fixed-Income Group provides services to institutions, municipalities and non-profit organizations. The Clearing and Execution Services Group is a provider of clearing and execution services to independent brokers/dealers throughout the US. RBC Capital Markets focuses on the following sectors: communications, media, consumer/retail, diversified industries, energy, financial institutions, forest products, healthcare, infrastructure finance, mining & metals, real estate, social infrastructure, technology and the US municipal markets. | Investment Banks/Brokers | Corporate Officer/Principal | |
Bluerock Therapeutics, Inc. | Corporate Officer/Principal | ||
Tapimmune, Inc. | Chief Tech/Sci/R&D Officer | ||
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Director/Board Member | |
Dlx Therapeutics L L C | Corporate Officer/Principal | ||
Rutgers Business School | College/University | Masters Business Admin | |
Universite Paris Est Creteil Val De Marne | College/University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 42 |
Vereinigtes Königreich | 6 |
Frankreich | 3 |
Hong Kong | 2 |
Deutschland | 2 |
Sektoral
Health Technology | 23 |
Consumer Services | 13 |
Commercial Services | 6 |
Finance | 4 |
Retail Trade | 2 |
Operativ
Director/Board Member | 49 |
Corporate Officer/Principal | 25 |
Independent Dir/Board Member | 18 |
Chief Tech/Sci/R&D Officer | 13 |
Director of Finance/CFO | 7 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Paul R. Fonteyne | 25 |
Isaac Cheng | 25 |
Camille Bedrosian | 18 |
Patrick Yeramian | 13 |
Jim Frates | 11 |
Kari Firestone | 9 |
Jeffrey Trigilio | 9 |
Daphne Quimi | 8 |
Gina Mazzariello | 5 |
Felix von Coerper | 3 |
- Börse
- Insiders
- Margaret Olinger
- Unternehmensverbindungen